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Abstract
Background: Many children and young people with juvenile idiopathic arthritis (JIA) experience delay in diagnosis
and access to right care. The reasons for delay are multi-factorial and influenced by patient and family, clinician and
organisational factors. Our aim was to explore the experiences of care, from initial symptoms to initial referral to
paediatric rheumatology.
Methods: We analysed one-to-one and joint qualitative interviews with families of children with JIA (n = 36)
presenting to a regional paediatric rheumatology service in the UK. We interviewed 51 family members (including
mothers, fathers, patients, grandmothers and an aunt) and 10 health professionals (including orthopaedic surgeons,
paediatricians, paediatric immunologist, General Practitioner and nurse) and a teacher involved in the care pathway
of these JIA patients. Interviews were audio-recorded and analysed according to the standard procedures of
rigorous qualitative analysis - coding, constant comparison, memoing and deviant case analysis.
Results: The median age of the children was 6 years old (range 1–17), with a spread of JIA subtypes. The median
reported time to first PRh MDT visit from symptom onset was 22 weeks (range 4-364 weeks). Three key factors
emerged in the pathways to appropriate care: (i) the persistence of symptoms (e.g. ‘change’ such as limp or
avoidance of previously enjoyed activities); (ii) the persistence of parents help-seeking actions (e.g. repeat visits to
primary and hospital care with concern that their child is not ‘normal’; iii) the experience and skills of health
professionals resulting in different trajectories (e.g. no-real-concern-at-this-point or further-investigation-is-required). JIA
was more likely to be considered amongst health practitioner if they had prior experiences of a child with JIA
(moreso with a ‘protracted pathway’) or exposure to paediatric rheumatology in their training. Conversely JIA was
more likely to be overlooked if the child had comorbidity such as learning disability or a chronic illness.
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Conclusions: Care pathways are often ‘turbulent’ prior to a diagnosis of JIA with physical and emotional distress for
families. There is need for greater awareness about JIA amongst health care professionals and observations of
change (from family and non-health care professionals such as teachers) are key to trigger referral for paediatric
rheumatology opinion.
Keywords: Access to care, Delayed diagnosis, Juvenile idiopathic arthritis, Help‐seeking behaviour, Outcome,
Primary care, Pathways of care.
Background
Juvenile idiopathic arthritis (JIA) is a heterogeneous
group of diseases with a spectrum of clinical features,
disease course and prognosis [1]. It is one of the most
common chronic inflammatory conditions in children
and young people (CYP) with a prevalence of at least 1
in 1000 [2]. JIA is typically a treatable condition with op-
timal outcomes associated with early diagnosis and ac-
cess to appropriate care [1, 3–5]. Delay has considerable
impact on quality of life with pain, fatigue, and ultim-
ately joint damage with functional disability; there is also
potential for extra-articular complications including vis-
ual loss from JIA associated uveitis as well as high mor-
bidity and potential mortality from macrophage
activation syndrome [1, 5–7].
Prompt referral to an experienced paediatric
rheumatology multidisciplinary team (PRh MDT) is
recommended as soon as the diagnosis is suspected
and in the UK the target is for the first assessment
within 4 weeks of referral and 10 weeks from the ini-
tial onset of symptoms [8]. Unfortunately, for many
CYP with incident JIA, delay in diagnosis and access
to appropriate treatment remains a common problem
reported around the world [3, 4, 9–12] and is a
source of frustration and anxiety for parents and CYP
[13, 14]. The reasons for delay are likely to be multi-
factorial [3, 4, 15, 16], can occur at any point in the
patient journey and may be influenced by a number
of contextual factors [3]: patient and family factors
(e.g. age, symptoms, carer concerns), clinician factors
(e.g. previous experience, skills, knowledge) and or-
ganisational factors (e.g. availability of specialist ad-
vice, referral pathways, distance to specialist services
and funding). These factors contribute to complex
and potentially protracted care pathways to be negoti-
ated by families between primary and specialist care
[17] involving multiple healthcare visits [7] and inves-
tigations [6, 15].
The aim of this study was to identify, describe and
understand determinants (barriers and drivers) to care in
the context of incident JIA to inform strategies to address
the challenges. Here we report findings of parental/guard-
ians accounts of patients’ trajectories from initial symp-
toms to initial referral to paediatric rheumatology.
Methods
We conducted in-depth qualitative interviews with the
parent / guardian of CYP diagnosed with incident JIA
presenting to a specialist regional paediatric rheumatol-
ogy service at the Great North Children’s Hospital, New-
castle Hospitals NHS Foundation Trust, Newcastle upon
Tyne, UK. Further participants from the families, health
and non-health care professionals involved in the path-
way of referral were recruited following the interview
with the parent / guardian. Interviews where conducted
face to face or over the telephone - with some interviews
being joint interviews (with CYP, partner or other family
member) - using topic guides and took place between
November 2008 and July 2011. All participants were
consented and older children (> 8 years) gave their
assent to take part in the study. Interviewees did not re-
ceive payment. The study received a favourable ethical
opinion from the Newcastle and North Tyneside 2 Re-
search Ethics Committee (07/Q0906/59).
Sampling strategy
Our sampling strategy was purposive to explore, test and
refine emerging ideas to explore and map the diversity
of factors that impact on delay and establish impact. We
undertook four phases of data collection, recruiting dif-
ferent participants for each phase:
 Typical case sampling [18], recruiting three groups of
families: (i) Interval from reported symptom onset to
diagnosis < 10 weeks; (ii) Interval 10–20 weeks; and
(iii) interval > 1 year ‘protracted delay’. This
approach was chosen to initially map some of the key
issues.
 Criterion sampling [18], recruiting families who had
received the diagnosis within the last 6 months. This
enabled checking of emerging ideas and generating
new areas to investigate.
 A further phase of criterion sampling, recruiting
families who had received a diagnosis for over six
months in order to validate our ideas with a different
group of patients.
 Theoretical sampling [18], focusing on cases with
very specific characteristics in order to test key
aspects of our findings.
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A more detailed account of the sampling process and
decisions has been outlined elsewhere [17] .
Data analysis
Interviews were audio-recorded, transcribed and edited
to ensure respondents anonymity. The initial topic guide
evolved during the course of data collection, allowing for
tailoring and gradual integration of a variety of follow-
up issues and topics. All analysis was initially conducted
by one of us (TR) according to the standard procedures
of rigorous qualitative analysis [19]. We used procedures
from first-generation grounded theory - coding, constant
comparison, memoing [20] - and from analytic induc-
tion, deviant case analysis [21]. Sampling, data collection
and analysis occurred concurrently, so that issues raised
in earlier phases of fieldwork were explored subse-
quently to enable conceptual saturation [22]. We ceased
sampling new cases when we deemed that we had
achieved both ‘code’ and ‘meaning’ saturation [22] and
that additional recruits would offer limited ability to ex-
tend ‘conceptual depth’ [23]. We also undertook regular
data sessions (joint analysis meetings) where the re-
search team share and exchange interpretations of key
issues emerging from the data. The research team in-
cluded social scientists and a paediatric rheumatologist
(HF). We did not use any qualitative data analysis soft-
ware to assist the formal analysis.
Results
Participants
We recruited 37 families - with one withdrawing from
the study prior to interview – and undertook interviews
to explore care pathways of 36 CYP with JIA. Patient de-
tails are described in Table 1. The median age was
6 years old (range 1–17), with a spread of JIA subtypes:
(oligoarticular n = 14; polyarticular n = 16; systemic n =
3; psoriatic n = 3). The median reported time to first
PRh MDT visit from symptom onset was 22 weeks
(range 4-364 weeks). Interview participants included
mothers (n = 34), fathers (n = 9), patients (n = 5), grand-
mothers (n = 2) and an aunt (n = 1). We also conducted
11 interviews with professionals: orthopaedic surgeons
(n = 4), paediatricians (n = 3), paediatric immunologist
(n = 1), General Practitioner [GP] (n = 1) nurse (n = 1)
and primary school teacher (n = 1).
Determinants influencing diagnosis and referral
Overall, three factors emerged as being central to the
pathways to appropriate care.
Persistence of symptoms
Parents reported either witnessing a change in their
child (e.g. observation of limp or joint swelling or change
in mood or functional ability) or their child complaining
(e.g. pain) albeit these complaints could be vague, espe-
cially in the younger children. In some cases the first
person to notice changes may not be the parent: a pri-
mary school teacher, a dentist, or other family member
looking after the child when symptoms first emerged.
Parents initially seek a ‘candidate explanation’ of the ini-
tial sign(s) and in so doing they understand them as tied
to one of the following factors:
 activities that the child has been undertaking (e.g.
playing sport or related to a fall).
 development of the child (e.g. ascribing symptoms as
‘growing pains’).
 ‘material’ environment (e.g. shoes too small or not
fitting properly).
 child’s temperament (e.g. ‘being awkward’, or ‘school
avoidance’).
Families have various courses of action open to them.
They may take no action as they rationalise the situation
as ‘unproblematic’, for example, by assuming that they
will ‘grow out of it’. They may also take a specific action:
 Apply some form of remedy, such as buying new
shoes or giving the child ‘over the counter’
medication.
 Seek more information. They may actively observe
the child’s joint or movements for a brief or extended
period looking for more evidence, or seek more details
about the problem from the child including whether
the child even feels it is a ‘problem’ for them, or
adopt a ‘wait and see’ approach.
 Seek advice and support from others. These others
include partner, family members or friends alongside
using resources such as the internet. In only five of
the 36 cases, did they seek advice from medical
professionals within 24 h.
In 18 cases, there was an interval between 1 week and
2 months for an initial visit to a medical professional. In
two further cases the interval was 8 months and 12
months and parents felt the initial features were related
to development of the child - the child had ‘funny square
knees’ and the other child had stiffness related to her
walking at a very young age and that her ‘muscles are
developing’. So prior to the initial visit to a health pro-
fessional parents engaged in a cycle of noticing, con-
structing an explanation and taking an appropriate
action (see Table 2).
Only when the severity of the same symptoms in-
creased or new physical, behavioural or mood features
emerged alongside the existing ones, or symptoms con-
tinued over a period of time that was regarded as ‘going
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Table 1 Patient characteristics (parent/guardian-reported at time of interview)
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1 3 F Systemic > 1 A&E 1 13 Paediatrics 22
2 12 M Oligo 1 GP 1 6 GP 364a
3 8 F Systemic > 1 GP 4 8 Paediatrics 9
5 7 M Poly 8 A&E 1 5 Orthopedics 4
6 1 M Oligo > 1 GP-Out of
Hours
2 13 Paediatrics 4
7 4 F Poly 1 GP 1 5 Orthopedics 20
8 11 F Oligo 4 GP 1 5 Orthopedics 26
9 5 F Oligo > 1 A&E 1 4 Orthopedics 26
10 5 M Oligo 2 GP 1 7 GP 13
11 2 M Systemic > 1 GP-Out of
Hours
4 8 Paediatrics 10
12 2 M Oligo 4 GP 1 13 Orthopedics 8
13 3 F Oligo 4 GP-Out of
Hours
1 11 Paediatrics 9
14 6 F Oligo 10 Health
Visitor
4 9 Unclear 26
15 6 F Oligo 5 Walk in
Centre
1 4 Paediatrics 8
16 8 F Poly 6 GP 3 3 GP 30
17 12 M Poly 3 GP 2 2 GP 286a
18 6 M Poly 4 GP 2 2 GP 7
19 16 F Psoriatic 8 GP 1 2 Dermatology 52
20 4 M Poly > 1 A&E 2 17 GP 17
21 17 F Poly Unclear GP 1 10 GP 20
22 13 F Poly 14 GP 1 2 Rheumatology 22
23 11 F Psoriatic 1 GP 6 6 GP 13
24 6 F Poly 8 GP 4 5 Paediatrics 26
25 13 F Poly 10 GP 1 3 GP 26
26 13 F Poly Unclear GP 2 5 A&E 260a
27 12 M Oligo 1 GP 1 2 GP 6
28 9 M Oligo > 1 GP 8 9 Orthopedics 32
29 7 M Oligo > 1 A&E 3 4 Orthopedics 13
30 17 M Poly N/A Secondary
(Paediatrics)
N/A 3 Paediatrics 104
31 3 F Oligo 32 Health
Visitor
10 16 A&E 52
32 5 F Oligo 1 GP 1 1 GP 4
33 5 F Poly 52 GP 4 12 Paediatric
Immunology
104
34 3 F Psoriatic 4 GP 2 4 Paediatrics 16
35 11 F Poly N/A Dental N/A 10 Paediatrics 208
36 5 F Poly 4 GP 2 5 Paediatrics 22
37 5 M Poly 12 GP 3 8 Paediatrics 77
aParticipants received diagnosis prior – Patient 2 at 16 weeks, Patient 17 at 10 weeks and Patient 26 at 130 weeks - but did not visit PRh MDT care
until this time point
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on for too long’, did parents seek medical opinion. In
five cases, the initial physical features triggered parents
to seek medical advice within 24 h of noticing the prob-
lem. The trigger in these cases was tied to a combination
of the following factors: clear change in the degree of
joint swelling; the potential seriousness of the lay-
diagnosis for the parents (concern about meningitis
given joint pains and a stiff neck; concern about vision
Table 2 Persistence of symptoms – examples of families accounts
Families developed ‘candidate explanations’
Prior to an initial visit to health professionals, families reported
engaging in cycles of noticing, constructing an explanation and taking
action
Middle of January he started complaining about his legs hurting, well his
leg in-particular but there was nothing to see so it was just, we were just
kind of brushing it off as growing pains and whatever else and we thought
it was a reaction, because [his] sibling had an operation we thought maybe
he wanted a bit of attention and then there were one day when he was
playing up with going to school and stuff like that “I don’t want to go to
school, I don’t want to go to school” and then one day just out of the blue
I was whipping his pyjama bottoms off to get him changed for school I
was like “Oh blimey your knee it is really swollen up” … this was about 2
weeks I think of complaining his leg was swollen, sore, before we could ac-
tually see anything. … Yeah I even bought him some cream, some normal
body lotion and said “Oh this is some magic cream it’s going to make you
better”. And I think it was literally the next day his knee swelled up and I
thought “Oh NO here we are brushing it to one side and there is some-
thing really wrong”. (Mother: P10, age 5–13 weeks to first PRh MDT visit,
Oligoarticulara)
No-real-concern-at-this-point trajectory
On visiting a health professional, some families reported they were told
further investigation is not needed at this time
He just woke up one morning with a big swollen arm and my daughter
thought he’d fallen out the bed or something and he she took him to the
doctors [GP] and all they said they kept saying “it was just inflamed” and
they were just giving him loads of different anti-inflammatory and things …
She was at the doctors [GP] every week, 8 weeks it was … They were just
saying “that [his arm] was inflamed, he might have knocked it” or whatever
but then because he couldn’t use it, it just went stiff and it was all swollen
… it was a case of “Oh he’s banged it” and “It’s just inflammation” they put
him on Ibuprofen and calpol and by the time he did get here [PRh MDT]
he couldn’t move. (Grandmother: P28, age 9–32 weeks to first PRh MDT
visit, Oligoarticular)
Further-investigation-is-required trajectory
As symptoms continue, escalate, or increase parents engage in repeat
visits and referrals to both primary and secondary care
… he walked round ‘funny’ for a day, he walked round with his neck back
so we got them to check it out … so we took him straight to [Out of
Hours Service] they checked him out … and then a few days later his neck
was fine but then he was struggling with his arms … so again we ended
up back at [Out of Hours Service] erm and again they checked him over
and they just thought it was post virus stiffness erm but then on the day
that I took him to Mum’s Group and “he was really not right and he
wouldn’t stand up … so I took him straight away to the actual doctors …
and he sent us straight away to casualty … straight away he was on calpol
erm to get his fever down … and he had no rash at that point but then
rashes over the next couple of days, they kept us in overnight to watch him
didn’t they. … the doctors put that down to any kind of viral rash they
weren’t sure at that point what it was erm … A lot of the doctors at the
time were just saying “its post viral, he’s had a cold and this is the virus
coming out” … So then over the next few weeks we were to-ing and fro-
ing because he just wasn’t getting any better, they gave us erm open ac-
cess to the hospital … They thought he might have had an infection in his
joints, so they x-rayed him and scanned him … they just kept on saying
“No its just part of his cold, he’s just got a virus and this is what part of it is
and it’ll go” and all this kind of stuff. … And this, this carried on and we
kept on going in and out so every couple of days and he didn’t seem to be
getting any better erm the rashes were on his body still and they were
coming round more of his joints like his elbows, his knees and erm basically
parts of his legs, sometimes on his back as well erm and there was like
slightly raised redness on there erm so again we went back in to hospital
with him, we had the open access and they came back and virtually said to
us, “Well look its this virus” (Mother & Father: P11, age 2–10 weeks to first
PRh MDT visit, Systemic)
aInformation about interviewee includes: (Interviewee type: Patient Number, Patient Age – Family member estimate of time from onset of symptoms to first visit
to PRh MDT, Diagnosis)
Rapley et al. Pediatric Rheumatology           (2021) 19:43 Page 5 of 11
(given that the child reported sore eyes and blurred vi-
sion); and the prompting from others to seek medical
help (grandparents, partner).
The parents sought advice from primary care services,
including General Practitioners, Out of Hours services -
by phone or visit - and Health Visitors, alongside Acci-
dent and Emergency (A&E) departments and ‘Walk in
Centres’. On these first visits two trajectories emerge.
 The first is a no-real-concern-at-this-point trajectory.
Medical practitioners offer analgesia (e.g.
‘paracetamol’), adopt a ‘wait and see’ attitude (e.g.
‘come back in two weeks if still a problem’), position
the concern as either not a problem (e.g. ‘nothing to
be worried about’), or a behavioural problem (e.g. ‘
sometimes [children] walk funny’) or a
developmental problem that does not require
further medical concern (e.g. ‘growing pains’). In
offering a reason for the diagnosis, practitioners
provide an account embedded in the same range of
factors that parents work with – namely, that the
problem is related to the child’s activities,
development, the material environment or
temperament. This pattern of multiple health care
visits continues until parents are referred to
secondary care (see Table 2). In the UK, secondary
care (i.e. hospital-based services such as general
paediatrics, orthopaedic surgery) as well as tertiary
care (sub-specialist services, such as paediatric
rheumatology) can only be accessed by referral from
primary care services, A&E or other hospital special-
ists. In our study, the referral to secondary or ter-
tiary care resulted after multiple (2->10) visits to
primary care or A&E.
 The second trajectory is further-investigation-is-
required. In this context, if the initial visit is to a GP,
the parents are referred to secondary care for
further diagnostic evaluation. Alternatively, if they
initially accessed care via out-of-hours services or a
walk-in-centre, they are instructed to consult their
own GP about the problem. However, once they are
initially referred to secondary (or tertiary) care, the
same pattern occurs. This can take 1->10 visits to
secondary care and in some cases tertiary care to re-
ceive a referral to PRh MDT and a diagnosis of JIA.
Parents can be discharged from secondary care and
then have to repeat the process, visiting primary
care to enable a referral to secondary care.
As symptoms continue or escalate parents engage in
repeat visits and referrals to both primary and secondary
care (including as an in-patient, often in a general paedi-
atric ward), to establish a diagnosis and instigate treat-
ment to manage the child’s symptoms (see Table 2).
Referral to secondary or tertiary care can be expedited
when there is a flare in symptoms or systemic upset (e.g.
fever) that coincides with a visit to a practitioner. How-
ever, referral is further delayed when the patient has
existing significant co-morbidities (e.g. dental problem
with a small jaw [likely due to complications of JIA];
learning disability [Downs syndrome]; another chronic
illness [psoriasis], known behavioural issues), or the fam-
ily is engaged with some aspect of health and social care
services (e.g. a parent with mental health problems or
the child is subject to a safeguarding concern / care
order) – in such cases the features are ascribed to other
co-morbidities and a physical cause overlooked. As a
mother (of a child with Down’s syndrome associated
arthritis) noted, ‘when they’ve got a diagnosis, everything
has to be related [to that]’ (Mother: P30, age 17–104
weeks to first PRh MDT visit, Polyarticular). This is an
example of anchoring bias [24] where initial diagnostic
ideas are retained, despite new (disconfirming) evidence.
In such cases, the search for a new diagnosis is delayed
by inappropriately assuming that new symptoms are ex-
plained by existing problems.
Parental persistence
Over the course of seeking a diagnosis and appropriate
care, parents initially trust the health professionals’ views
and are willing to accept their clinical opinion. However,
over time, doubts enter parents’ minds, as their child is
‘still unwell’ despite repeated consultations. Parents have
to manage the tension between trust and questioning
the (diagnostic) expertise of health professionals. In one
case, the parents sought to manage this tension through
an experiment. They had been repeatedly told by their
GP that the child’s lack of mobility and desire to be car-
ried was that she was ‘a little bit of a lazy child’; so they
placed chocolate at one end of the room and the child
‘dragged herself towards it’ (see Table 3). Although a
dramatic example, it echoes the experiences of parents,
in that they can begin to doubt themselves, and the ad-
vice given to them resulting in loss of trust to make
judgements about the health of their child.
Parents have to continue to search for a diagnosis and
treatment despite often feeling that health professionals
perceive them as overly ‘anxious’, ‘worried’, ‘pushy’ or
‘wasting’ (professionals) time. In extreme cases they may
even overhear this or be told directly by a health profes-
sional. At times, this feeling of concern about being la-
belled is compounded by fluctuation in the child
symptoms and presenting with a ‘well child’ when
assessed by the health professional (see Table 3). In
order to address the ‘well child’ problem, parents may
plan visits in order to align with a flare in symptoms
(e.g. in the mornings) in order to demonstrate to practi-
tioners’ the ‘symptoms-in-action’.
Rapley et al. Pediatric Rheumatology           (2021) 19:43 Page 6 of 11
Parents engage in repeat visits to primary and second-
ary care due to a powerful sense of concern that what is
going on with their child is not ‘normal’. Over time, par-
ents get frustrated with the lack of a convincing solution
to their child problems. Some parents directly ask for a
second (or even third) opinion. Some gain second opin-
ions by chance (see Table 3). For example by seeking an
appointment with their usual GP and being told they are
away and so resulting in being assessed by a different
GP. Some gain a second opinion by design, for example
by requesting an appointment with a different partner in
a GP practice, going straight to A&E, visiting a walk-in-
centre, changing practice or waiting for their GP practice
to close before contacting them and so getting access to
their out-of-hours service. In two cases, parents used
private medical care for the first time to expedite referral
to specialist opinion.
In maximising the number of different practitioners
that they visit, in timing visits to align with flares in
symptoms, or in repeatedly visiting the same practi-
tioner, they seek to maximise the chance of either
receiving a solution or being referred to another who
may be able to offer a solution. In two cases other life
circumstances (family bereavement) resulted in the par-
ents being not wholly focused on the escalation of their
child symptoms. In another case, the child had co-
morbidities, and the initial onset of problems with the
child’s toes was the ‘least of our problems’ (Mother: P19,
age 16–1 year to first PRh MDT visit, Polyarticular).
Therefore, without consistent parental persistence, delay
can be extended even further.
Experience and skills of Health Professionals
Parents reported frustration with the uncertainty of a
diagnosis and multiple consultations with different
health professionals. This pattern of clinical activity
seemed to lead to frustration for health professionals
(see Table 4). If they positioned the child as on the no-
real-concern-at-this-point trajectory they seemed to be
frustrated with the parents. If the child was on the fur-
ther-investigation-is-required trajectory, they could be-
come frustrated with “need to name” the disease.
Table 3 Parental Persistence – examples of families’ accounts
Trusting health professionals views
Families have to manage the tension between trust and
questioning the expertise of health professionals
For instance we’d even try things at home which you’d know every child would be
fooled by so you’d sit her at the other end of the room “do you want this chocolate
bar” and she’d drag herself across the floor and you’d think well no child is going to
drag themselves for chocolate they’re going to be up and running for it, so I mean to
me that’s a fool proof plan (Father: P33, age 5–104 weeks to first PRh MDT visit,
Polyarticular)
Managing your own feelings
On visiting a health professional, some families reported
they felt they were perceived as overly ‘anxious’
[At A&E] she started to sort of come round by then, her finger had gone down a bit
and I had sort of explained you know we have been having problems … this kid has
been poorly since Boxing Day we need to do something. … while we were actually
there she actually came back to life and she was running round like a lunatic again
and you sort of think hang on a minute, they are looking at you as if to say neurotic
mother (laughter). (Mother: P01, age 3–22 weeks to first PRh MDT visit, Systemic)
Seeking second opinions
Some families explicitly worked to see different health
professionals other saw different ones by chance
And then one day at A&E a doctor said “Are you happy with what I’ve said” and I
went “Not really” … I was a bit, when they were trying to say like it was nothing
basically I wasn’t too happy. … me Mam wasn’t happy and I think they could tell we
weren’t happy, … they referred us to the A&E clinic so I had to come back and see a
doctor in the A&E clinic, they still said there was nothing wrong with her so I still said
I wasn’t happy so they said they’d refer her to a consultant, luckily the one in [local
town] was on compassionate leave and they said I could hang on till they came back
or come to the [other town] (Mother: P31, age 3–52 weeks to first PRh MDT visit,
Oligoarticular).
I think for the third or fourth time … we had another set of x-rays done erm and a
very stroppy consultant telling us that it was “all in her head” erm but, you know, “for
goodness sake there was nothing on the x-ray”. … [another consultant] decided that
we could come back to the fracture clinic the next morning and they would plaster
her wrist as a precaution. … So erm we were trying to negotiate with the sister on
the plaster clinic to, can we come at a different time … I knew the lady she said “Give
me a moment I’ll ring the consultant upstairs, the adult rheumatologist” and she said
“You need to come with me he’s actually up on the children’s ward” because he did
different clinics “He’s got both sets of x-rays up on his computer screen as we speak”
(laughs) we went to see him … we went up and he had both sets of x-rays on his
screen side by side and that was the very first time he said “She had arthritis” and he
said he wanted to refer her to [a different] hospital (Mother: P21, age 17–20 weeks to
first PRh MDT visit, Polyarticular)
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In four cases, in the initial or second presentation to
health practitioners, JIA was considered as part of the
differential and raised as a potential diagnosis with par-
ents. All but one of these children were then referred
directly to the paediatric rheumatology team and the
other to an adult rheumatology service. In other cases,
JIA might have been raised at some point along the
child’s trajectory, but health professionals reported as
excluding JIA as the child did not appear unwell, was
not in pain and/or they expected blood tests be able to
confirm the diagnosis. Additionally, in some cases when
inflammation is considered they may initially diagnose
‘reactive arthritis’. With persistent symptoms, reactive
arthritis is then excluded and the child is routinely re-
ferred to paediatric rheumatology (see Table 4). How-
ever, as outlined above, in the context of a child with
significant co-morbidities (e.g. dental problem with a
small jaw [likely due to complications of JIA]; learning
disability [Downs syndrome]; another chronic illness
[psoriasis], known behavioural issues), some health pro-
fessionals reported reticence to revise a diagnosis even
when patients’ symptoms continue over an extended
period of time (see Table 4).
Certain factors emerged to promote a practitioner
considering a proposed or tentative diagnosis of JIA.
‘Hands on’ experience about JIA can be related to past
experiences, in relation to memorable lectures, periods
of training, or working alongside personnel from a
paediatric rheumatology service. Awareness can be in-
creased where the practitioner has been involved in a
prior encounter of a child with JIA and more so with a
‘protracted pathway’ of a child in the past. As one parent
put it, ‘ … it’s just getting to see the right person at the
right time isn’t it ?…’ (Mother – P31, age 3–52 weeks
first PRh MDT visit, Oligoarticular). However, even
when a diagnosis of JIA is given, three parents felt that
their child was not treated optimally, as they were not
referred to paediatric rheumatology services. In one case,
the child was given a brief period of physiotherapy in
adult services and discharged relatively quickly, accord-
ing to the mother, ‘because of his age they didn’t want
to put him through all of these tests’ (Mother - P02, age
Table 4 Experience and Skills of Health Professionals – examples of families and health professionals accounts
Parental frustration
Families often reported being frustrated with the
uncertainty around the diagnosis
We’ve been to [Hospital One] fracture clinic, we’ve been to see another specialist they just
kept sending us to see different specialists, we’ve been to [Hospital Two] ward to see
somebody … they just didn’t seem like they had a clue. … They were just passing her
backwards and forwards, fair enough it is hard with kids … We were passed back and
forwards and nobody had a clue what was going on erm and they were seeing her in this
pain but they couldn’t do nothing for her (Mother: P14, age 6–26 weeks to first PRh MDT visit,
Oligoarticular)
Health Professional frustration
Some families reported how health professional also
appeared to be frustrated
You get to the stage when you feel like a pest when you’re ringing … One of the nurses I
actually heard her on the phone, I rang and my phone didn’t have much signal where we live
and I’d rang her on a Friday night because his neck was bad so the nurse had put a doctor on
the phone and I was saying he’s been discharged but he’s got open access he’s on diclofenac,
his necks bad, he’s got a temperature again and she couldn’t hear us properly and I went I’ll
ring back and she went “And I can’t be bothered with this, with her with this problem” on the
end of the phone. (Mother: P20, age 4–17 weeks to first PRh MDT visit, Polyarticular)
Differential diagnoses
Health professionals needed to exclude other
diagnosis prior to referral
You see the child could have anything else which is acute in nature and you need to really
rule that out before I refer it, so it is kind of bottom of the list that er a child will be suffering
from inflammatory arthritis (Orthopedic Surgeon: P12, age 2–8 weeks to first PRh MDT visit,
Oliogoarticular)
Things clearly weren’t getting better so you know we were clearly having to start thinking
about other diagnoses as being more likely. … It wasn’t that I saw [P06] and thought “Gosh
this looks very much like so and so” I think it was more a process of, erm, quite simply you
know from what you read and what you are taught from text books you have a particular
expectation of what something like a reactive arthritis should do and erm if its not doing that
then you have got to think about other diagnoses. Now obviously you know I have seen a lot
more cases of reactive arthritis than I have of inflammatory arthritis and perhaps another way
of putting it is maybe its more to do with the fact that it was ceasing to look like a reactive
arthritis rather than it was reminiscent of a child with an inflammatory arthritis. (General
Practitioner: P6, age 1–4 weeks to first PRh MDT visit, Oliogoarticular)
Well it’s not a case of pushing it’s a case of she wasn’t listening. It was all Down syndrome in
her eyes, it had to be something to do with the Downs and it wasn’t and because it, the
stiffness was spreading in his neck and elbows and everything he was completely seized up!
But it had to be Downs related. (Mother: P30, age 17–104 weeks to first PRh MDT visit,
Polyarticular)
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12–364 weeks to first PRh MDT visit, Oligoarticular).
Over time, as the disease continued to flare, they were
then referred to paediatric rheumatology and treatment
escalated rapidly.
Discussion
Delay in access to PRh care is a widespread problem and
remains so even when specialist services are available [4,
5]. The impact of delay is considerable and given the
highly effective treatments available [1, 3, 23], it is more
imperative than ever that efforts are made to facilitate
earlier diagnosis and prompt referral to specialist care.
Our study adds novel insights into key, and often
interlinked factors that influence pathways to PRh care.
We have described these broadly under key categories of
persistence of symptoms, persistence of parents help-
seeking actions and experience of health professionals.
The referral to PRh care is invariably made by a health
care professional in primary or secondary care and likely
influenced to some degree by each of these factors.
Our dataset, with one exception, suggests that care
pathways are often turbulent in terms of the effort fam-
ilies have to undertake in terms of repeat visits, the
range and number of alternative diagnoses suggested,
treatments offered and investigations endured prior to a
diagnosis of JIA. The process and uncertainty often in-
curs physical and emotional distress. The complexity
and turbulence was apparent whether the child has their
first assessment within the UK recommended time
frame [8] of 10 weeks or longer. Given the distress that
can emerge, there is a need for awareness across the
PRh MDT of the potential emotional impact, as well as
increased access to appropriate resources at the time of
diagnosis.
Our research highlights that health practitioners who
see children need the appropriate experience and skills
to consider a diagnosis of JIA; this includes prior experi-
ence of a child with JIA or exposure in some form to the
PRh care (in clinical practice or a teaching/training
event). It is known that many clinicians to whom chil-
dren may present, lack self-reported confidence in their
MSK clinical examination skills [24] and many doctors
in primary care have not had training in paediatrics [25].
This may well contribute to the reported delay for other
significant MSK diseases in CYP such as Slipped Upper
Femoral Epiphysis [26] and cancer affecting bone and
joint [27].
Messages from our work focus on the need for greater
awareness about JIA, knowledge and skills to assess chil-
dren appropriately, knowing when to consider JIA as a
diagnosis and when to refer. Education and skills train-
ing needs to be targeted at those who are most actively
involved in the care pathways of children, namely gen-
eral practitioners, paediatricians, Accident & Emergency
practitioners, orthopaedic surgeons, school nurses and
allied health professionals. The educational messages
can actually be quite simple, such as ‘JIA is not rare’,
‘children with JIA often appear well’, ‘pain may not be
verbalised’, ‘there is no diagnostic test’, ‘basic blood tests
and radiographs can be normal’; and ‘rheumatoid factor
is invariably negative’ [28]. Our work suggests that the
‘ideal time’ to educate practitioners is when they have
been involved in the care pathway of a patient with JIA
and especially if the patient journey has been protracted.
Clearly how this education is delivered requires sensitiv-
ity and needs to focus on being instructive rather than
being critical. It is also important to consider the role of
other professionals that work regularly with children.
Paediatric physiotherapists will often assess children in
the community and can likely ‘flag’ a child with sus-
pected MSK pathology including JIA – this concept is
the basis for the RightPath model of triage in the com-
munity - [29]. Furthermore, teachers and nursery
workers also have a key role to raise concerns about a
child as they know the child well and can notice changes
that may indicate inflammatory joint problems: in the
child’s abilities (e.g. handwriting, play, sport), avoidance
of activities that they find difficult (e.g. avoiding sitting
cross legged on the floor or holding a pencil in the other
hand). Teachers are often trusted by families and have
an important role to support and empower families to
seek health care even if they don’t necessarily know what
the cause of the problem is.
Raising awareness in the general population that ‘chil-
dren do get arthritis too!’ is key and initiatives led by par-
ents and CYP themselves are powerful ways to reach a
wider audience and empower other families to seek
medical attention. The emergence of social media and
the internet has greatly increased capacity to share pa-
tient stories at low cost and wide reach [30] and the
WORD day global awareness of JIA campaign exempli-
fies the impact of parents and CYP working alongside as
partners with health care professionals to have wide
reach and gather momentum [14].
Our study has several limitations. First, it was con-
ducted in one region in UK and pathways of referral
may differ in other parts of the world, for example, dir-
ect access to paediatricians rather than via primary care.
Nonetheless we suggest that our findings are relevant to
services elsewhere especially given that delay in access to
care is a widespread problem. The Interviews with fam-
ilies were subject to issues of recall as families were
asked to comment on retrospective events, which may
have been months to years after diagnosis. We did not
interview PRh about their perspective on their patients’
delays in diagnosis and future work should explore their
insights into the process. Finally, our data was collected
nearly 10 years ago (data collection ended July 2011) and
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so elements of the findings may be seen as no longer
relevant, given changes in care. However, we know that
delays in diagnosis remain a major problem impacting
on clinical care [12] and are a priority to address in
many parts of the world [31]; we suggest that the factors
identified are still central to influencing that delay.
Conclusions
This study describes the often turbulent care pathways
prior to a diagnosis of JIA. Three factors – the persist-
ence of symptoms, parental persistence and the experi-
ence of health professionals - need to align for a child
with incident JIA to receive a diagnosis and appropriate
care. Like the board game, snakes and ladders, this align-
ment process often happens through moments of ‘luck’
and ‘chance’. Health practitioners who see children need
the appropriate experience and skills to consider a diag-
nosis of JIA. Educational messages need to be pitched at
the appropriate level of complexity and targeted to both
the myriad of health and non-health professionals who
may prompt the diagnosis and the referral process.
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